1. A. For each patient, a physician shall submit a report to the Department, either personally or through a representative, for the levels of lead and within the time periods specified in Table 3.1, Criteria for Physician Reporting of Blood Lead Levels.

2. B. A physician shall ensure that the report required in subsection (A) includes the following information:

   1. 1. The patient’s name, address, and telephone number;
   2. 2. The patient’s date of birth;
   3. 3. The patient’s gender, race, and ethnicity;
   4. 4. If the patient is an adult, the patient’s occupation and the name, address, and telephone number of the patient’s employer;
   5. 5. Whether the blood collected from the patient was venous blood or capillary blood;
   6. 6. The date the blood was collected;
   7. 7. The results of the blood lead level test;
   8. 8. The date of the test result;

   9. 9. If the test result indicates a blood lead level greater than or equal to 25 µg of lead per dL of whole blood for an adult or greater than or equal to 3.5 µg of lead per dL of whole blood for a child:

      1. a. The funding source for the medical services provided to the patient and, if applicable, the name of the patient’s health plan and the identification number for the patient assigned by the health plan;
      2. b. The language predominantly spoken in the patient’s home, if known; and

      3. c. If the patient is a child:

         1. i. The name of the patient’s parent or guardian, and
         2. ii. Whether the child is a refugee;
   10. 10. The date the physician performed the point-of-care test for blood lead or received the test result from a clinical laboratory;
   11. 11. If applicable, the name, address, and telephone number of the clinical laboratory that tested the blood; and
   12. 12. The name, practice name, address, and telephone number of the physician who performed the point-of-care test for blood lead or received the test result from the clinical laboratory.
3. C. For each blood lead level test, a clinical laboratory director shall submit a report to the Department, either personally or through a representative, for the levels of lead and within the time periods specified in Table 3.2, Criteria for Clinical Laboratory Director Reporting of Blood Lead Levels.

4. D. A clinical laboratory director shall ensure that the report required in subsection (C) includes the following information:

   1. 1. The patient’s name, address, and telephone number;
   2. 2. The patient’s date of birth;
   3. 3. The patient’s gender, race, and ethnicity;
   4. 4. If the patient is an adult, the patient’s occupation and the name, address, and telephone number of the patient’s employer if known;
   5. 5. The name, practice name, address, and telephone number of the physician who ordered the test;
   6. 6. If known, the funding source for the test for blood lead, the name of the patient’s health plan, and the identification number for the patient assigned by the health plan;
   7. 7. Whether the blood collected from the patient was venous blood or capillary blood;
   8. 8. The date the blood was collected;
   9. 9. The results of the blood lead level test;
   10. 10. The date of the test result;
   11. 11. The name and address of the clinical laboratory that tested the blood; and
   12. 12. The name and telephone number of the clinical laboratory director.

5. E. A physician or clinical laboratory director, either personally or through a representative, shall submit the report required in subsection (A) or (C):

   1. 1. By telephone;
   2. 2. In person;
   3. 3. In a document sent by fax, delivery service, or mail; or
   4. 4. Through an electronic reporting system authorized by the Department.

Table 3.1. Criteria for Physician Reporting of Blood Lead Levels

Historical Note

Table 3.1 made by final rulemaking at 25 A.A.R. 3429, effective January 1, 2020 (Supp. 19-4).

Table 3.2. Criteria for Clinical Laboratory Director Reporting of Blood Lead Levels

Historical Note

Table 3.2 made by final rulemaking at 25 A.A.R. 3429, effective January 1, 2020 (Supp. 19-4).

Historical Note

New Section renumbered from R9-4-301 and amended by final rulemaking at 7 A.A.R. 55, effective December 12, 2000 (Supp. 00-4). Amended by final rulemaking at 25 A.A.R. 3429, effective January 1, 2020 (Supp. 19-4). Amended by final rulemaking at 31 A.A.R. 1309 (April 24, 2025), effective June 2, 2025 (Supp. 25-2).